Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARTIVION, INC.AORT · Entity 4767 | Chief Commercial Officer | March 02, 2026 | March 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARTIVION, INC.
Report date March 02, 2026 · Filed March 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 230,794 |
Ending reported balance
After 2026-03-03 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-02 · Grant · Acquired 28,845 · Balance 235,367 F1: Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one third (1/3) on February 28, 2028, assuming employment on the relevant vesting date. Row 2 · 2026-03-03 · Sale · Disposed 4,573 · Balance 230,794 F2: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one third (1/3) on February 28, 2028, assuming employment on the relevant vesting date.
F2: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2026 Filed Mar 4, 2026 23:49 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 4,573 | $37.78 | $172,747.82 |
DisclosureSEC source: 0001628280-26-014892 · wk-form4_1772668162.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,794 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 19:49 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 2,784 | $38.02 | $105,861.32 |
DisclosureSEC source: 0001628280-26-013672 · wk-form4_1772567369.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,522 F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 23:49 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 28,845 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-014892 · wk-form4_1772668162.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,367 F1 · shares: Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one third (1/3) on February 28, 2028, assuming employment on the relevant vesting date. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 22:30 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 20,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011820 · wk-form4_1772058656.xml · nonDerivative · entry 3 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,306 F3 · shares: Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 22:30 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 2,075 | $35.69 | $74,062.98 |
DisclosureSEC source: 0001628280-26-011820 · wk-form4_1772058656.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,868 F2 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:30 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 3,773 | $37.59 | $141,819.52 |
DisclosureSEC source: 0001628280-26-011820 · wk-form4_1772058656.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,943 F1 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 20:47 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 5,000 | $45.11 | $225,550.00 |
DisclosureSEC source: 0001628280-25-057614 · wk-form4_1766004447.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,842 F1 · price: Reflects the price the shares were sold. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 18:03 UTC | ARTIVION, INC. AORT · Entity 4767 | Exercise / conversionStock Options (Right to buy) · Derivative | 6,394 | $0.00 Strike: $29.62 | $0.00 |
DisclosureSEC source: 0001628280-25-052820 · wk-form4_1763488988.xml · derivative · entry 6 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,394 shares Expires 2026-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2025. F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 5, 2020. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 18:03 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 6,394 | $45.17 | $288,816.98 |
DisclosureSEC source: 0001628280-25-052820 · wk-form4_1763488988.xml · nonDerivative · entry 4 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 198,842 F1 · shares: The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2025. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 18:03 UTC | ARTIVION, INC. AORT · Entity 4767 | Exercise / conversionCommon Stock | 6,394 | $29.62 | $189,390.28 |
DisclosureSEC source: 0001628280-25-052820 · wk-form4_1763488988.xml · nonDerivative · entry 3 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 205,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2025. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 18:03 UTC | ARTIVION, INC. AORT · Entity 4767 | Exercise / conversionStock Options (Right to buy) · Derivative | 6,393 | $0.00 Strike: $29.62 | $0.00 |
DisclosureSEC source: 0001628280-25-052820 · wk-form4_1763488988.xml · derivative · entry 5 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,393 shares Expires 2026-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2025. F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 5, 2020. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 18:03 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 6,393 | $44.67 | $285,575.31 |
DisclosureSEC source: 0001628280-25-052820 · wk-form4_1763488988.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 198,842 F1 · shares: The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2025. Read SEC document |
| November 14, 2025 Filed Nov 18, 2025 18:03 UTC | ARTIVION, INC. AORT · Entity 4767 | Exercise / conversionCommon Stock | 6,393 | $29.62 | $189,360.66 |
DisclosureSEC source: 0001628280-25-052820 · wk-form4_1763488988.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 205,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2025. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 17:10 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 6,563 | $45.86 | $300,966.05 |
DisclosureSEC source: 0001628280-25-052266 · wk-form4_1763140209.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,842 F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| November 10, 2025 Filed Nov 13, 2025 01:07 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 3,373 | $44.62 | $150,499.89 |
DisclosureSEC source: 0001628280-25-051793 · wk-form4_1762996064.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,405 F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 13:56 UTC | ARTIVION, INC. AORT · Entity 4767 | Exercise / conversionStock Options (Right to buy) · Derivative | 10,802 | $0.00 Strike: $26.24 | $0.00 |
DisclosureSEC source: 0001653206-25-000003 · wk-form4_1755179807.xml · derivative · entry 3 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,802 shares Expires 2027-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was February 19, 2021. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 13:56 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 10,802 | $43.67 | $471,755.75 |
DisclosureSEC source: 0001653206-25-000003 · wk-form4_1755179807.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,778 F1 · price: Reflects weighted average price. Range of prices were between $43.470 to $43.835. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 13:56 UTC | ARTIVION, INC. AORT · Entity 4767 | Exercise / conversionCommon Stock | 10,802 | $26.24 | $283,444.48 |
DisclosureSEC source: 0001653206-25-000003 · wk-form4_1755179807.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2025 Filed Jan 28, 2026 20:50 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 874 | $24.30 | $21,239.95 |
DisclosureSEC source: 0001628280-26-003822 · wk-form5_1769633452.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,716 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 19:32 UTC | ARTIVION, INC. AORT · Entity 4767 | Exercise / conversionStock Options (Right to buy) · Derivative | 15,910 | $0.00 Strike: $21.55 | $0.00 |
DisclosureSEC source: 0000784199-25-000059 · wk-form4_1741807937.xml · derivative · entry 3 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,910 shares Expires 2025-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 12, 2019. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 19:32 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 15,100 | $23.61 | $356,548.75 |
DisclosureSEC source: 0000784199-25-000059 · wk-form4_1741807937.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 208,778 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 30, 2024. F2 · price: Reflects weighted average price. Range of prices were between $23.14 to $23.89. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 19:32 UTC | ARTIVION, INC. AORT · Entity 4767 | Exercise / conversionCommon Stock | 15,910 | $21.55 | $342,860.50 |
DisclosureSEC source: 0000784199-25-000059 · wk-form4_1741807937.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 223,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 30, 2024. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:06 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 2,618 | $24.80 | $64,938.70 |
DisclosureSEC source: 0000784199-25-000051 · wk-form4_1741640754.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,968 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:06 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 25,654 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-25-000051 · wk-form4_1741640754.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,586 F1 · shares: Represents performance stock units granted on February 23, 2024. One third (1/3) were issued on March 6, 2025. The remaining shares earned in connection with the February 2024 grant will be eligible to vest and be issued as follows: one third (1/3) on February 23, 2026; and one third (1/3) on February 23, 2027, assuming employment on the relevant vesting date. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 19:59 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 24,301 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-25-000033 · wk-form4_1741118390.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,932 F1 · shares: Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 18:54 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 2,035 | $27.31 | $55,567.71 |
DisclosureSEC source: 0000784199-25-000018 · wk-form4_1740596042.xml · nonDerivative · entry 4 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,631 F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 18:54 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 985 | $27.31 | $26,896.41 |
DisclosureSEC source: 0000784199-25-000018 · wk-form4_1740596042.xml · nonDerivative · entry 3 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,666 F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 18:54 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 591 | $27.31 | $16,137.85 |
DisclosureSEC source: 0000784199-25-000018 · wk-form4_1740596042.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,651 F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 18:54 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 2,846 | $27.31 | $77,712.88 |
DisclosureSEC source: 0000784199-25-000018 · wk-form4_1740596042.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,242 F1 · shares: These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| June 30, 2024 Filed Jan 30, 2025 15:16 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 1,398 | $15.20 | $21,249.60 |
DisclosureSEC source: 0000784199-25-000006 · wk-form5_1738250165.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,088 F1 · price: These shares were acquired pursuant to Artivion Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt pursuant to 16b-3. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 23:14 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 2,022 | $18.72 | $37,856.29 |
DisclosureSEC source: 0000784199-24-000104 · wk-form4_1709853255.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,637 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| March 05, 2024 Filed Mar 14, 2024 23:48 UTC Amendment | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 2,022 | $18.72 | $37,856.29 |
DisclosureSEC source: 0000784199-24-000112 · wk-form4a_1710460104.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,690 F3 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary transaction. F2 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| March 01, 2024 Filed Mar 7, 2024 23:14 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 5,724 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000104 · wk-form4_1709853255.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,659 F1 · shares: Represents LTIP performance stock units of which one hundred percent (100%) were issued on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 14, 2024 23:48 UTC Amendment | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 5,724 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000112 · wk-form4a_1710460104.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,712 F1 · shares: Represents LTIP performance stock units of which one hundred percent (100%) were issued on March 1, 2024. F2 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 22:32 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 584 | $19.83 | $11,583.29 |
DisclosureSEC source: 0000784199-24-000084 · wk-form4_1709245936.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,935 F1 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 27, 2024 Filed Mar 15, 2024 00:16 UTC Amendment | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 584 | $19.83 | $11,583.29 |
DisclosureSEC source: 0000784199-24-000136 · wk-form4a_1710461791.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,988 F1 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary transaction. F2 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 22:12 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 1,904 | $20.27 | $38,596.17 |
DisclosureSEC source: 0000784199-24-000065 · wk-form4_1709158363.xml · nonDerivative · entry 4 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,519 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 22:12 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 1,610 | $20.27 | $32,636.47 |
DisclosureSEC source: 0000784199-24-000065 · wk-form4_1709158363.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,687 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 26, 2024 Filed Mar 15, 2024 00:27 UTC Amendment | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 1,875 | $20.27 | $38,008.31 |
DisclosureSEC source: 0000784199-24-000146 · wk-form4a_1710462424.xml · nonDerivative · entry 4 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,572 F5 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,904 shares were sold, when in fact, 1,875 shares were sold. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 26, 2024 Filed Mar 15, 2024 00:27 UTC Amendment | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 1,586 | $20.27 | $32,149.96 |
DisclosureSEC source: 0000784199-24-000146 · wk-form4a_1710462424.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,711 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,610 shares were sold, when in fact, 1,586 shares were sold. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 23:10 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 19,734 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000053 · wk-form4_1708989044.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,911 F1 · shares: Represents shares of restricted stock that vest 33 1/3% per year beginning on the first anniversary of the grant date, pursuant to the terms of the Equity and Cash Incentive Plan. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 22:12 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 12,736 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000065 · wk-form4_1709158363.xml · nonDerivative · entry 3 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,423 F3 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date. Read SEC document |
| February 23, 2024 Filed Feb 28, 2024 22:12 UTC | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 5,386 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000065 · wk-form4_1709158363.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,297 F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024. Read SEC document |
| February 23, 2024 Filed Mar 15, 2024 00:27 UTC Amendment | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 12,736 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000146 · wk-form4a_1710462424.xml · nonDerivative · entry 3 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,447 F4 · shares: Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date. F3 · balance_after: As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4. Read SEC document |
| February 23, 2024 Filed Mar 15, 2024 00:27 UTC Amendment | ARTIVION, INC. AORT · Entity 4767 | GrantCommon Stock | 5,386 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-24-000146 · wk-form4a_1710462424.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,279 F1 · shares: Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 22:32 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 496 | $18.87 | $9,357.04 |
DisclosureSEC source: 0000784199-24-000024 · wk-form4_1708641140.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,177 F2 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 22:32 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 2,060 | $18.87 | $38,861.90 |
DisclosureSEC source: 0000784199-24-000024 · wk-form4_1708641140.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,673 F1 · shares: These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:22 UTC | ARTIVION, INC. AORT · Entity 4767 | Exercise / conversionStock Option (Right to Buy) · Derivative | 13,562 | $16.30 Strike: $16.30 | $221,060.60 |
DisclosureSEC source: 0000784199-24-000002 · wk-form4_1704403334.xml · derivative · entry 3 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,562 shares Expires 2024-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 02/21/2018. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:22 UTC | ARTIVION, INC. AORT · Entity 4767 | SaleCommon Stock | 13,562 | $18.00 | $244,116.00 |
DisclosureSEC source: 0000784199-24-000002 · wk-form4_1704403334.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 128,733 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 23, 2023. F2 · price: Reflects the price the shares were sold. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:22 UTC | ARTIVION, INC. AORT · Entity 4767 | Exercise / conversionCommon Stock | 13,562 | $16.30 | $221,060.60 |
DisclosureSEC source: 0000784199-24-000002 · wk-form4_1704403334.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 23, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.